News and Reports

Globe
  • Upstream Bio Presents New Phase 1 Clinical Data on UPB-101 at the American Thoracic Society (ATS) International Conference

    22 May 2023
    Download
  • Numab Therapeutics Announces First Subject Dosed in Phase 1 Clinical Study of NM26 Program

    15 May 2023
    Download
  • Swixx and Beigene Partner in 13 Countries of Central and Eastern Europe, Greece, Cyprus and Malta

    9 May 2023
    Download
  • SphingoTec's Innovative IVD Product sphingotest® penKid® Receives First IVDR Certificate

    9 May 2023
    Download
  • Antiva Biosciences Closes $53 Million Series E Equity Financing Led by MPM-BioImpact Capital and Names Kristine Ball President and CEO

    27 April 2023
    Download
  • Sai Life Sciences opens SSRL, a dedicated research facility for Schrödinger, at its Hyderabad R&D Campus

    20 April 2023
    Download
  • ArriVent Biopharma Closes $155 Million Oversubscribed Series B Financing

    27 March 2023
    Download
  • Mineralys Therapeutics Announces Pricing of Upsized Initial Public Offering

    9 February 2023
    Download
  • Neuron23 Announces First-in-Human Dose in Phase 1 Clinical Trial of its Best-in-Class Brain-Penetrant LRRK2 Inhibitor for Parkinson’s Disease

    7 February 2023
    Download
  • SWIXX and BioCryst partner for ORLADEYO® (berotralstat) in Central and Eastern Europe

    24 January 2023
    Download
  • SWIXX and Jazz Pharmaceuticals expand partnership with agreement to now distribute EPIDYOLEX® (CANNABIDIOL) in CEE territory

    20 January 2023
    Download
  • Sai Life Sciences inks strategic agreement to set up Schrödinger’s first dedicated offshore Research Laboratories in India

    10 January 2023
    Download
  • SWIXX and Kyowa Kirin expand Partnership for Rare Disease Portfolio to 13 Countries in Europe

    19 December 2022
    Download
  • Mineralys Therapeutics Announces Positive Topline Phase 2 Data for MLS-101 in the Target-HTN Trial Evaluating the Treatment of Uncontrolled and Resistant Hypertension

    16 November 2022
    Download
  • Boditech Med and SphingoTec close global licensing agreement for kidney function biomarker Proenkephalin A 119-159 (penKid)

    15 November 2022
    Download
  • Swixx and Kyowa Kirin enter into Partnership for Rare Disease Medicines Portfolio in Poland

    10 October 2022
    Download
  • Shape Memory Medical Completes Enrollment in the AAA-SHAPE Early Feasibility Study

    29 August 2022
    Download
  • Upstream Bio Announces Dosing of First Patient in a Phase 1b Clinical Trial of UPB-101 in Asthma

    9 August 2022
    Download
  • Vascular Dynamics Completes $20 Million Equity Financing to Support Further Clinical Evaluations of MobiusHD Device

    12 July 2022
    Download
  • Galera Announces Results from Phase 1 Stage of GRECO-1 Trial of Rucosopasem with SBRT for NSCLC

    29 June 2022
    Download
  • Aculys Pharma initiates collaboration with Ubie with the aim of building a “sleep ecosystem”

    29 June 2022
    Download
  • Akoya Biosciences to Partner with Acrivon Therapeutics for the Clinical Development of Acrivon’s Proprietary OncoSignature® Test into a Companion Diagnostic

    28 June 2022
    Download
  • Acrivon Therapeutics Receives FDA Clearance for Innovative Phase 2 Trial to Treat Ovarian, Endometrial and Urothelial Cancer Patients Based on Predicted Sensitivity to ACR-368

    22 June 2022
    Download
  • Galecto Announces First Patient Enrolled in Phase 2 Trial of GB1211 in Combination with Atezolizumab for First-Line Treatment of NSCLC

    16 June 2022
    Download
  • Dren Bio Announces $65 Million Series B Financing to Advance its Lead Asset into the Clinic

    14 June 2022
    Download